Levi & Korsinsky, LLP
CLASS ACTION UPDATE for JRVR, ATHA and BZ: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / July 22, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
JRVR Shareholders Click Here: https://www.zlk.com/pslra-1/james-river-group-holdings-ltd-information-request-form?prid=17869&wire=1
ATHA Shareholders Click Here: https://www.zlk.com/pslra-1/athira-pharma-inc-loss-submission-form?prid=17869&wire=1
BZ Shareholders Click Here: https://www.zlk.com/pslra-1/kanzhun-limited-information-request-form?prid=17869&wire=1
* ADDITIONAL INFORMATION BELOW *To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
James River Group Holdings, Ltd. (NASDAQ:JRVR)
JRVR Lawsuit on behalf of: investors who purchased August 1, 2019 - May 5, 2021
Lead Plaintiff Deadline: September 7, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/james-river-group-holdings-ltd-information-request-form?prid=17869&wire=1
According to the filed complaint, during the class period, James River Group Holdings, Ltd. made materially false and/or misleading statements and/or failed to disclose that: (1) James River had not adequately reserved for its Uber policies; (2) James River was using an incorrect methodology for setting reserves that materially understated the Company's true exposure to Uber claims; (3) as a result, James River was forced to increase its unfavorable reserves in subsequent quarters even after cancelling the Uber policies; and (4) as a result of the foregoing, Defendants' statements about James River's business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.
Athira Pharma, Inc. (NASDAQ:ATHA)
This lawsuit is on behalf of investors who purchased Athira Pharma, Inc. (NASDAQ: ATHA) between September 18, 2020 and June 17, 2021 and/or purchased common stock in or traceable to the Company's registration statement issued in connection with the Company's September 2020 initial public offering priced at $17.00 per share.
Lead Plaintiff Deadline : August 24, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/athira-pharma-inc-loss-submission-form?prid=17869&wire=1
According to the filed complaint, (1) the research conducted by Defendant Kawas, which formed the foundation for Athira's product candidates and intellectual property, was tainted by Kawas' scientific misconduct, including the manipulation of key data through the altering of Western blot images; and (2) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and omitted material facts necessary in order to make the statements made not misleading.
Kanzhun Limited (NASDAQ:BZ)
BZ Lawsuit on behalf of: investors who purchased June 11, 2021 - July 2, 2021
Lead Plaintiff Deadline: September 10, 2021
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/kanzhun-limited-information-request-form?prid=17869&wire=1
According to the filed complaint, during the class period, Kanzhun Limited made materially false and/or misleading statements and/or failed to disclose that: (1) Kanzhun would face an imminent cybersecurity review by the Chinese government ("CAC"); (2) the CAC would require Kanzhun to suspend new user registration on its BOSS Zhipin app; (3) Kanzhun needed to "to conduct a comprehensive examination of cybersecurity risks"; (4) Kanzhun needed to "enhance its cybersecurity awareness and technology capabilities"; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
SOURCE: Levi & Korsinsky, LLP
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
Planet 13 Holdings6.8.2021 00:12:19 CEST | Press release
Planet 13 Illinois Wins Chicago License
Monarch Mining Corporation5.8.2021 22:46:35 CEST | Press release
Monarch Mining Corporation Announces the Closing of the $11.25 Million Transaction With Gold Royalty Corp.
Adcore Inc.5.8.2021 21:01:58 CEST | Press release
Adcore Announces Conference Call to Discuss Second Quarter 2021 Financial Results
Linkfire5.8.2021 19:52:26 CEST | Press release
Linkfire Expands Agreement with Global Tech Company
ReelTime Rentals Inc5.8.2021 15:19:06 CEST | Press release
OTC Markets Upgrades RLTR to Highest Designation of Providing Current Information Meeting Upcoming Amended SEC Rule15c2-11 Guidelines
New Jersey Mining Company5.8.2021 15:02:35 CEST | Press release
New Jersey Mining Co. Receives Trademark Approvals and Advances Apparel Brand with Release of its "Flynn" Skeleton Series and "Toughest Hat in Your Closet" Campaign
Engage People5.8.2021 15:02:15 CEST | Press release
Engage People Named in 'Now Tech: Promotions and Offer Management Providers, Q3 2021' Report by Independent Research Firm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom